Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation

Abroug Fekri, Ouanes-Besbes Lamia, Fkih-Hassen Mohamed, Ouanes Islem, Ayed Samia, Dachraoui Fahmi, Brochard Laurent, ElAtrous Souheil

Source: Eur Respir J 2014; 43: 717-724
Journal Issue: March
Disease area: Airway diseases, Respiratory critical care

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Abroug Fekri, Ouanes-Besbes Lamia, Fkih-Hassen Mohamed, Ouanes Islem, Ayed Samia, Dachraoui Fahmi, Brochard Laurent, ElAtrous Souheil. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J 2014; 43: 717-724

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019
Year: 2020



Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

A randomised placebo-controlled trial of doxapram in acute hypercapnic respiratory failure complicating exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 444s
Year: 2003

Morphine for refractory breathlessness in COPD: a randomized clinical intervention study
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016

Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


A randomised controlled trial to investigate the optimal dose and effect of salbutamol for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002

The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial
Source: Eur Respir J, 57 (6) 2003338; 10.1183/13993003.03338-2020
Year: 2021



ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



Procalcitonin-guided antibiotic therapy in acute exacerbations of COPD (AECOPD): a randomised trial - The ProCOLD Study
Source: Eur Respir J 2005; 26: Suppl. 49, 464s
Year: 2005

Randomized controlled trial of nebulized budesonide suspension in acute severe exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002

Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009



A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial
Source: Eur Respir J, 50 (1) 1601448; 10.1183/13993003.01448-2016
Year: 2017



Placebo-controlled, double-blind trial of chronic, intermittent ‘pulse‘ therapy of moxifloxacin to prevent acute exacerbations in COPD patients with chronic bronchitis: baseline data
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006


Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



A multi-centre, randomised controlled trial of positive expiratory pressure mask therapy for inpatients with acute exacerbations of COPD and sputum expectoration
Source: Annual Congress 2013 –Rehabilitation, exercise and adjunct physiotherapy techniques in different respiratory conditions
Year: 2013